WebTechnical analysis trends ZHEJIANG STARRY PHARMACEUTICAL CO.,LTD. Technical analysis Income Statement Evolution More Financials Consensus Consensus EPS … WebCurrently, Jian Hu holds the position of Vice Chairman, Board Secretary & General Manager at Zhejiang Starry Pharmaceutical Co., Ltd. and Chairman of Zhejiang …
603520.CN Company Profile & Executives - Zhejiang Starry Pharmaceutical ...
WebAs on March 28, 2024, The transaction has been considered and approved by directors of the Zhejiang Starry Pharmaceutical Co.,Ltd. Within 7 trading days from the date of signing the contract, the entire transaction price of 35 million yuan will be paid to the company's designated account at one time. WebSee the company profile for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their compensation. narrow head motorcycle helmet
ZHEJIANG Stock Top Management (CN:603520) - Macroaxis
WebSee the company profile and updated insider trades of Zhejiang Starry Pharmaceutical Co., Ltd. (603520). Learn more about the sector, industry, classification, employee size, and executives of ... WebHu Jian, deputy chairman and general manager of Stellite Pharmaceuticals, sends his love and blessing to Xianju Fifth Elementary School 2024-04-12 Hu Jinsheng, Chairman of Stellite Pharmaceuticals, is on the 5th Top Ten Charity Stars Hu Jinsheng, Chairman of Stellite Pharmaceuticals, is on the 5th Top Ten Charity Stars 2024-10-29 WebMar 3, 2024 · Zhejiang Starry Pharmaceutical Co., Ltd. announced that it has received CNY 671.999962 million in funding from a group of investors Aug 08. New 90-day high - … melhik marketing and communication